These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35491217)

  • 1. [Immune-mediated thrombotic thrombocytopenic purpura and susceptible HLA alleles].
    Sakai K
    Rinsho Ketsueki; 2022; 63(4):277-285. PubMed ID: 35491217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overlapping ADAMTS13 peptide binding profiles of DRB1∗08:03 and DRB1∗11:01 suggest a common etiology of immune-mediated thrombotic thrombocytopenic purpura.
    Sakai K; Miyadera H; Kubo M; Nakajima F; Matsumoto M
    J Thromb Haemost; 2023 Mar; 21(3):616-628. PubMed ID: 36696200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DR.
    Sakai K; Kuwana M; Tanaka H; Hosomichi K; Hasegawa A; Uyama H; Nishio K; Omae T; Hishizawa M; Matsui M; Iwato K; Okamoto A; Okuhiro K; Yamashita Y; Itoh M; Kumekawa H; Takezako N; Kawano N; Matsukawa T; Sano H; Ohshiro K; Hayashi K; Ueda Y; Mushino T; Ogawa Y; Yamada Y; Murata M; Matsumoto M
    Blood; 2020 Jun; 135(26):2413-2419. PubMed ID: 32253422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura.
    Laghmouchi A; Graça NAG; Voorberg J
    Front Immunol; 2021; 12():757192. PubMed ID: 34858410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of HLA alleles involved in immune thrombotic thrombocytopenic purpura patients from Turkey.
    Kikili Cİ; Kivanç D; Ortaboz D; Şentürk Çiftçi H; Özbalak MM; Yenerel MN; Nalçaci M; Ar MC; Oğuz FS; Beşişik SK
    Blood Coagul Fibrinolysis; 2024 Sep; 35(6):307-315. PubMed ID: 39083057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura.
    Mancini I; Ricaño-Ponce I; Pappalardo E; Cairo A; Gorski MM; Casoli G; Ferrari B; Alberti M; Mikovic D; Noris M; Wijmenga C; Peyvandi F;
    J Thromb Haemost; 2016 Dec; 14(12):2356-2367. PubMed ID: 27762046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of human leukocyte antigen DRB1-DQB1 haplotypes in the susceptibility to acquired idiopathic thrombotic thrombocytopenic purpura.
    Sinkovits G; Szilágyi Á; Farkas P; Inotai D; Szilvási A; Tordai A; Rázsó K; Réti M; Prohászka Z
    Hum Immunol; 2017 Feb; 78(2):80-87. PubMed ID: 27866840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers.
    Hrdinová J; D'Angelo S; Graça NAG; Ercig B; Vanhoorelbeke K; Veyradier A; Voorberg J; Coppo P
    Haematologica; 2018 Jul; 103(7):1099-1109. PubMed ID: 29674502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of human leukocyte antigens as predisposing and/or protective factors in patients with idiopathic thrombotic thrombocytopenic purpura.
    John ML; Hitzler W; Scharrer I
    Ann Hematol; 2012 Apr; 91(4):507-10. PubMed ID: 22203269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-mediated thrombotic thrombocytopenic purpura in patients with and without systemic lupus erythematosus: a retrospective study.
    Yue C; Su J; Fan X; Song L; Jiang W; Xia J; Shi T; Zhang X; Li X
    Orphanet J Rare Dis; 2020 Aug; 15(1):225. PubMed ID: 32859237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of von Willebrand factor high-molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpura.
    Béranger N; Benghezal S; Savigny S; Capdenat S; Joly BS; Coppo P; Stepanian A; Veyradier A
    Thromb Res; 2019 Sep; 181():29-35. PubMed ID: 31330376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ADAMTS13
    Gilardin L; Delignat S; Peyron I; Ing M; Lone YC; Gangadharan B; Michard B; Kherabi Y; Sharma M; Pashov A; Latouche JB; Hamieh M; Toutirais O; Loiseau P; Galicier L; Veyradier A; Kaveri S; Maillère B; Coppo P; Lacroix-Desmazes S
    Haematologica; 2017 Nov; 102(11):1833-1841. PubMed ID: 28751567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential HLA-DRB1*11-dependent presentation of CUB2-derived peptides by ADAMTS13-pulsed dendritic cells.
    Sorvillo N; van Haren SD; Kaijen PH; ten Brinke A; Fijnheer R; Meijer AB; Voorberg J
    Blood; 2013 Apr; 121(17):3502-10. PubMed ID: 23372163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HLA Variant rs6903608 Is Associated with Disease Onset and Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Caucasians.
    Mancini I; Giacomini E; Pontiggia S; Artoni A; Ferrari B; Pappalardo E; Gualtierotti R; Trisolini SM; Capria S; Facchini L; Codeluppi K; Rinaldi E; Pastore D; Campus S; Caria C; Caddori A; Nicolosi D; Giuffrida G; Agostini V; Roncarati U; Mannarella C; Fragasso A; Podda GM; Birocchi S; Cerbone AM; Tufano A; Menna G; Pizzuti M; Ronchi M; De Fanti A; Amarri S; Defina M; Bocchia M; Cerù S; Gattillo S; Rosendaal FR; Peyvandi F
    J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33096882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association Between Human Leukocyte Antigens and ITP, TTP, and HIT.
    Amin Asnafi A; Jalali MT; Pezeshki SMS; Jaseb K; Saki N
    J Pediatr Hematol Oncol; 2019 Mar; 41(2):81-86. PubMed ID: 30543580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-ADAMTS13 autoantibodies in immune-mediated thrombotic thrombocytopenic purpura do not hamper ELISA-based quantification of ADAMTS13 antigen.
    Dekimpe C; Roose E; Tersteeg C; Joly BS; Dewaele A; Horta S; Pareyn I; Vandenbulcke A; Deckmyn H; Feys HB; Tellier E; Kaplanski G; Scully M; Coppo P; De Meyer SF; Veyradier A; Vanhoorelbeke K
    J Thromb Haemost; 2020 Apr; 18(4):985-990. PubMed ID: 31989742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAMTS13 conformation and immunoprofiles in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura.
    Sakai K; Matsumoto M; De Waele L; Dekimpe C; Hamada E; Kubo M; Tersteeg C; De Meyer SF; Vanhoorelbeke K
    Blood Adv; 2023 Jan; 7(1):131-140. PubMed ID: 36306339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-mediated thrombotic thrombocytopenic purpura plasma induces calcium- and IgG-dependent endothelial activation: correlations with disease severity.
    Tellier E; Widemann A; Cauchois R; Faccini J; Lagarde M; Brun M; Robert P; Robert S; Bachelier R; Poullin P; Roose E; Vanhoorelbeke K; Coppo P; Dignat-George F; Kaplanski G
    Haematologica; 2023 Apr; 108(4):1127-1140. PubMed ID: 36453103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ.
    Hrdinová J; Verbij FC; Kaijen PHP; Hartholt RB; van Alphen F; Lardy N; Ten Brinke A; Vanhoorelbeke K; Hindocha PJ; De Groot AS; Meijer AB; Voorberg J; Peyron I
    Haematologica; 2018 Jun; 103(6):1083-1092. PubMed ID: 29567779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura.
    Bonnez Q; Sakai K; Vanhoorelbeke K
    J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.